Halidor [Bencyclane]

Vascular diseases:
Inside Halidor® administered 100 mg 3 times / day. within 2-3 months. The maximum daily dose for oral administration is 400 mg. The interval between courses is 2-3 months.
The drug can also be used in the form of intravenous infusion in a daily dose of 200 mg divided into 2 administrations. Before the infusion, 100 mg (4 ml) of the drug is diluted in 100-200 ml of isotonic sodium chloride solution and injected into / into the drip for 1 hour 2 times / day.
To eliminate spasm of internal organs:
Inside Halidor® prescribed in a dose of 100-200 mg once, but not more than 400 mg / day. For maintenance therapy prescribed 100 mg 3 times / day. for 3-4 weeks, then 100 mg 2 times / day. The duration of treatment is determined individually depending on the disappearance of the symptoms of the disease and, as a rule, does not exceed 1-2 months.
In acute cases, Halidor® is administered intravenously slowly at a dose of 100–200 mg (4–8 ml) or intramuscularly at a dose of 50 mg (2 ml). Before the on / in the introduction of the required amount of solution diluted with isotonic sodium chloride solution to 10-20 ml. The course of treatment is 2-3 weeks with the subsequent transfer of the patient, if necessary, to the intake of the drug Halidor®.

Adequate and strictly controlled clinical studies on the use of the drug Halidor® during pregnancy and lactation have not been conducted. Therefore, the introduction of the drug in patients in the first trimester of pregnancy is not recommended.
If necessary, the use of the drug during lactation should decide on the termination of breastfeeding during treatment.
The data of preclinical studies did not reveal any embryotoxic or teratogenic effects.

With the simultaneous appointment of Halidor with drugs that cause hypokalemia, cardiac glycosides, with drugs that inhibit myocardial function, the daily dose of Halidor should not exceed 150-200 mg.
In case of parenteral administration, the injection sites should be changed, since The drug may cause damage to the vascular endothelium and thrombophlebitis.
Patients with severe cardiovascular or respiratory failure predisposed to collapse, as well as prostatic hypertrophy and urinary retention (the degree of delay increases with the relaxation of the bladder muscles) should be avoided from parenteral administration.
With long-term use of Halidor, systematic (at least 1 time in 2 months) laboratory tests of the rheological properties of blood are recommended.
Influence on ability to drive motor transport and control mechanisms
At the beginning of a course of treatment, patients should take special care when driving vehicles and other potentially hazardous activities.

Symptoms: an increase in heart rate, decreased blood pressure, collapse, impaired renal function, urinary incontinence, drowsiness, anxiety, in severe cases - epileptiform convulsive seizures. Significant overdose can cause tonic and clonic convulsions. Allergic reactions.
Treatment: symptomatic therapy. When taking a large number of pills should be a gastric lavage. Benzodiazepines are recommended for the treatment of seizures. The specific antidote is not known. There is no data on the possible elimination of a benziklan by dialysis.